Co-D Therapeutics, Inc. is a preclinical stage biopharmaceutical company based in Madison, Wisconsin. Co-D is an innovative drug development company dedicated to developing first-in-class combination nano-medicines with high safety profiles to treat cancer. Co-D’s nanotechnology based polymeric micelle delivery system enables the formulation and combinatorial delivery of multiple anticancer agents in a single novel therapeutic. This approach eliminates toxic carriers, permits safe dose-escalation and facilitates multi-drug delivery thereby maximizing the therapeutic index.
View Top Employees from Co-D Therapeutics| Website | http://www.co-drx.com |
| Revenue | $5 million |
| Employees | 4 (1 on RocketReach) |
| Founded | 2012 |
| Address | 821 E Washington Ave Suite 200, Madison, Wisconsin 53703, US |
| Phone | (608) 358-9655 |
| Technologies |
JavaScript,
HTML,
PHP
+8 more
(view full list)
|
| Industry | Biotechnology, Pharmaceutical Manufacturing, Business Services General, Business Services, Science and Engineering, Drug Discovery, Clinical Trials, Health Care, Nanotechnology, Pharmaceutical |
| Competitors | Accuronix Therapeutics, Inc., Cascade Prodrug, Incorporated, ENB Therapeutics, Intensity Therapeutics, Inc., Targazyme |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 541714 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies |
Looking for a particular Co-D Therapeutics employee's phone or email?
Co-D Therapeutics Questions
The Co-D Therapeutics annual revenue was $5 million in 2024.
J Patrick Genn is the Acting Executive Chairman of Co-D Therapeutics.
1 people are employed at Co-D Therapeutics.
Co-D Therapeutics is based in Madison, Wisconsin.
The NAICS codes for Co-D Therapeutics are [54, 54171, 541714, 541, 5417].
The SIC codes for Co-D Therapeutics are [87, 873].
Top Co-D Therapeutics Employees
Related Companies
